• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表征具有流感血凝素的植物来源病毒样颗粒的先天刺激能力。

Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.

机构信息

Departments of Physiology and Microbiology & Immunology, Goodman Cancer Research Center, 3655 Promenade Sir William Osler, Montréal, Québec H3G 1Y6, Canada.

Medicago Inc., 1020 route de l'Église, suite 600, Québec, Québec G1V 3V9, Canada.

出版信息

Vaccine. 2018 Dec 18;36(52):8028-8038. doi: 10.1016/j.vaccine.2018.10.099. Epub 2018 Nov 14.

DOI:10.1016/j.vaccine.2018.10.099
PMID:30448064
Abstract

Cell-mediated immunity is an important component of immediate and long-term anti-viral protection. Dendritic cells (DCs) are essential for the induction of cell-mediated immunity by instructing the activation and differentiation of antigen-specific T cell responses. Activated DCs that express co-stimulatory molecules and pro-inflammatory cytokines are necessary to promote the development of type 1 immune responses required for viral control. Here we report that plant-derived virus-like particles (VLPs) bearing influenza hemagglutinins (HA) directly stimulate mouse and human DCs. DCs exposed to H1- and, to a lesser extent, H5-VLPs in vitro rapidly express co-stimulatory molecules and produce pro-inflammatory cytokines including IL-12, IL-6 and TNFα. Furthermore, these VLPs support the activation and differentiation of antigen-specific T cell responses. Mechanistically, H1-VLPs stimulate the activation of kinases typically activated downstream of pattern recognition receptors including AKT, p38, and p42/44 ERK. In vivo, immunization with plant-derived VLPs induce the accumulation of both cDC1s and cDC2 in the draining lymph node and a corresponding increase in T and B cells. VLPs devoid of HA protein activate DCs, suggesting they are intrinsically immunostimulatory. Together, the results demonstrate that these candidate plant-derived VLP vaccines have an inherent and direct stimulatory effect on DCs and can enhance the ability of DCs to promote Type 1 immune responses.

摘要

细胞介导的免疫是即时和长期抗病毒保护的重要组成部分。树突状细胞 (DCs) 通过指导抗原特异性 T 细胞反应的激活和分化,对于诱导细胞介导的免疫至关重要。表达共刺激分子和促炎细胞因子的激活 DC 对于促进控制病毒所需的 1 型免疫反应的发展是必要的。在这里,我们报告了携带流感血凝素 (HA) 的植物来源病毒样颗粒 (VLPs) 可直接刺激小鼠和人类 DCs。体外暴露于 H1-和(在较小程度上)H5-VLPs 的 DCs 迅速表达共刺激分子并产生促炎细胞因子,包括 IL-12、IL-6 和 TNFα。此外,这些 VLPs 支持抗原特异性 T 细胞反应的激活和分化。从机制上讲,H1-VLPs 刺激通常在模式识别受体下游激活的激酶的激活,包括 AKT、p38 和 p42/44 ERK。在体内,用植物来源的 VLPs 免疫会导致引流淋巴结中 cDC1 和 cDC2 的积累,以及 T 和 B 细胞的相应增加。缺乏 HA 蛋白的 VLPs 激活 DCs,表明它们具有内在的免疫刺激性。总之,这些结果表明这些候选植物源性 VLP 疫苗对 DCs 具有固有和直接的刺激作用,并增强了 DCs 促进 1 型免疫反应的能力。

相似文献

1
Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.表征具有流感血凝素的植物来源病毒样颗粒的先天刺激能力。
Vaccine. 2018 Dec 18;36(52):8028-8038. doi: 10.1016/j.vaccine.2018.10.099. Epub 2018 Nov 14.
2
Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.通过电子显微镜对植物来源的流感病毒血凝素样颗粒疫苗进行形态学表征。
Vaccine. 2018 Apr 12;36(16):2147-2154. doi: 10.1016/j.vaccine.2018.02.106. Epub 2018 Mar 14.
3
Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.携带季节性(H1)或禽流感(H5)血凝素的植物源病毒样颗粒疫苗在体外与人类免疫细胞有不同的相互作用模式。
Vaccine. 2017 May 2;35(19):2592-2599. doi: 10.1016/j.vaccine.2017.03.058.
4
Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.使用结构优化的RIG-I激动剂作为佐剂增强流感病毒样颗粒疫苗接种。
J Virol. 2015 Oct;89(20):10612-24. doi: 10.1128/JVI.01526-15. Epub 2015 Aug 12.
5
Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.展示流感病毒蛋白并诱导保护性免疫的禽病毒衣壳发育的结构基础。
J Virol. 2015 Mar;89(5):2563-74. doi: 10.1128/JVI.03025-14. Epub 2014 Dec 17.
6
A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.一种二价异源DNA病毒样颗粒初免-加强疫苗可引发针对1型和2型甲型流感病毒的广泛保护。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02052-16. Print 2017 May 1.
7
Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages.携带流感血凝素(HA)的植物源病毒样颗粒重现了天然流感病毒粒子与人类单核细胞/巨噬细胞的早期相互作用。
Vaccine. 2017 Aug 16;35(35 Pt B):4629-4636. doi: 10.1016/j.vaccine.2017.07.012. Epub 2017 Jul 13.
8
Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.靶向交叉呈递树突状细胞上Xcr1的疫苗分子可诱导针对流感病毒的保护性CD8+ T细胞反应。
Eur J Immunol. 2015 Feb;45(2):624-35. doi: 10.1002/eji.201445080. Epub 2014 Dec 28.
9
A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response.单剂量肌内注射植物源病毒样颗粒疫苗可引发平衡的体液和细胞免疫反应,尽管体液免疫反应较弱或缺失,但仍能保护幼龄和老龄小鼠免受甲型H1N1流感病毒攻击。
Clin Vaccine Immunol. 2017 Dec 5;24(12). doi: 10.1128/CVI.00273-17. Print 2017 Dec.
10
Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.在HEK-293悬浮培养中产生的含有血凝素和神经氨酸酶的病毒样颗粒:一种有效的流感疫苗候选物。
Vaccine. 2016 Jun 17;34(29):3371-80. doi: 10.1016/j.vaccine.2016.04.089. Epub 2016 May 5.

引用本文的文献

1
Translatability scoring in prospective and retrospective COVID drug development cases.前瞻性和回顾性 COVID 药物开发病例中的可翻译性评分。
Eur J Clin Pharmacol. 2023 Aug;79(8):1051-1071. doi: 10.1007/s00228-023-03517-0. Epub 2023 Jun 6.
2
Dose immunogenicity study of a plant-produced influenza virus-like particle vaccine in layer hens.植物源流感病毒样颗粒疫苗在蛋鸡中的剂量免疫原性研究。
Heliyon. 2022 Jun 25;8(6):e09804. doi: 10.1016/j.heliyon.2022.e09804. eCollection 2022 Jun.
3
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance.
影响疫苗性能的重组血凝素流感疫苗的独特特性。
NPJ Vaccines. 2021 Dec 2;6(1):144. doi: 10.1038/s41541-021-00403-7.
4
Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?对抗人类病毒性疾病:植物源疫苗会是答案吗?
Vaccines (Basel). 2021 Jul 8;9(7):761. doi: 10.3390/vaccines9070761.
5
Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.国际植物科学界在抗击人类传染病方面的贡献 - 第 1 部分:传染病和大流行疾病。
Plant Biotechnol J. 2021 Oct;19(10):1901-1920. doi: 10.1111/pbi.13657. Epub 2021 Jul 19.
6
What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?植物源疫苗技术能为抗击新冠疫情带来什么?
Vaccines (Basel). 2020 Apr 14;8(2):183. doi: 10.3390/vaccines8020183.
7
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages.植物源病毒样颗粒疫苗可驱动人单核细胞衍生巨噬细胞对甲型流感血凝素肽进行交叉呈递。
NPJ Vaccines. 2019 May 15;4:17. doi: 10.1038/s41541-019-0111-y. eCollection 2019.